Reumatolog Ali Theibich ApS: Financial statements 2020
CVR: 39336022
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Reumatolog Ali Theibich ApS (CVR 39336022) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,030,027 and a net result of DKK 777,452 compared with DKK 70,844 the year before. That is an increase of 542.1% compared with the year before. Equity in the 2020 report amounted to DKK 858,117. The solvency ratio was 42.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,030,027
- Profit/Loss
- DKK 777,452
- Equity
- DKK 858,117
- Total Assets
- DKK 2,016,025
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2M | 777K | 858K | 1 |
| 2019 | - | 316K | 71K | 81K | 1 |
| 2018 | - | 188K | 10K | 10K | 0 |
Official annual report
How creditworthy is Reumatolog Ali Theibich ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Reumatolog Ali Theibich ApS has published its annual report for 2019. Gross profit came to DKK 316,132, and the net result was DKK 70,844.
About Reumatolog Ali Theibich ApS
Reumatolog Ali Theibich ApS is a Danish company of the type Anpartsselskab based in Næstved, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Ali Theibich IVS. The management consists of Ali Ahmed Theibich. The company is owned by Speciallægen Wedian Holding ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,497,333 and a net result of DKK -92,479 compared with DKK 216,289 the year before. Equity in the 2025 report amounted to DKK 1,265,681.
